ZA200505461B - Pyridine derivatives usefl for inhibiting sodium/calcium exchange system - Google Patents

Pyridine derivatives usefl for inhibiting sodium/calcium exchange system Download PDF

Info

Publication number
ZA200505461B
ZA200505461B ZA200505461A ZA200505461A ZA200505461B ZA 200505461 B ZA200505461 B ZA 200505461B ZA 200505461 A ZA200505461 A ZA 200505461A ZA 200505461 A ZA200505461 A ZA 200505461A ZA 200505461 B ZA200505461 B ZA 200505461B
Authority
ZA
South Africa
Prior art keywords
yloxy
chroman
pyridin
nmr
mhz
Prior art date
Application number
ZA200505461A
Other languages
English (en)
Inventor
Leena Otsomaa
Arto Karjalainen
Piero Pollesello
Tuula Koskelainen
Sirpa Rasku
Jouko Levijoki
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8565286&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200505461(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corp filed Critical Orion Corp
Publication of ZA200505461B publication Critical patent/ZA200505461B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D411/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200505461A 2003-01-09 2006-01-24 Pyridine derivatives usefl for inhibiting sodium/calcium exchange system ZA200505461B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20030030A FI20030030A0 (fi) 2003-01-09 2003-01-09 Uusia yhdisteitä

Publications (1)

Publication Number Publication Date
ZA200505461B true ZA200505461B (en) 2006-03-29

Family

ID=8565286

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200505461A ZA200505461B (en) 2003-01-09 2006-01-24 Pyridine derivatives usefl for inhibiting sodium/calcium exchange system

Country Status (22)

Country Link
US (1) US7482340B2 (sr)
EP (1) EP1583759A1 (sr)
JP (1) JP2006516271A (sr)
KR (1) KR20050095601A (sr)
CN (1) CN100457752C (sr)
AR (1) AR042733A1 (sr)
AU (1) AU2004203943B2 (sr)
BR (1) BRPI0406669A (sr)
CA (1) CA2512184A1 (sr)
EA (1) EA008539B1 (sr)
FI (1) FI20030030A0 (sr)
HR (1) HRP20050703A2 (sr)
IL (1) IL169435A0 (sr)
IS (1) IS7969A (sr)
MX (1) MXPA05007435A (sr)
NO (1) NO20053730L (sr)
NZ (1) NZ541087A (sr)
PL (1) PL378326A1 (sr)
RS (1) RS20050528A (sr)
UA (1) UA81941C2 (sr)
WO (1) WO2004063191A1 (sr)
ZA (1) ZA200505461B (sr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20011507A0 (fi) * 2001-07-10 2001-07-10 Orion Corp Uusia yhdisteitä
KR101233223B1 (ko) * 2004-12-21 2013-02-14 제이엔씨 석유 화학 주식회사 크로만환을 가지는 액정 화합물, 액정 조성물 및 이 액정조성물을 함유하는 액정 표시소자
UA109896C2 (xx) * 2007-02-22 2015-10-26 Похідні імінопіридину та їх застосування як мікробіоцидів
EP2649066B1 (en) * 2010-12-06 2015-10-21 Autifony Therapeutics Limited Hydantoin derivatives useful as kv3 inhibitors
EP2524908A1 (en) * 2011-05-20 2012-11-21 LEK Pharmaceuticals d.d. Process for the preparation of alfa-substituted ketones and their application in synthesis of pharmaceutically active compounds
SI2567958T1 (sl) 2011-09-12 2015-01-30 Sanofi Substituirani 2-(kroman-6-iloksi)-tiazoli in njihova uporaba kot farmacevtiki
WO2013037388A1 (en) 2011-09-12 2013-03-21 Sanofi Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
JP5941637B2 (ja) * 2011-09-12 2016-06-29 サノフイ 置換2−(クロマン−6−イルオキシ)−チアゾール及び医薬としてのその使用
US8912224B2 (en) 2011-09-12 2014-12-16 Sanofi Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
WO2013144191A1 (de) * 2012-03-29 2013-10-03 Bayer Intellectual Property Gmbh Substituierte 2 -amino - 3 - cyanopyridine als inhibitoren des natrium calcium austausches und ihre verwendung bei kardiovaskulären erkrankungen
TWI633095B (zh) * 2013-03-08 2018-08-21 賽諾菲公司 經取代-6-基氧基-環烷類及其作為醫藥品之用途
GB201416186D0 (en) 2014-09-12 2014-10-29 Redx Pharma Ltd Compounds
EP3265445B1 (en) 2015-03-06 2021-05-05 Pharmakea, Inc. Lysyl oxidase-like 2 inhibitors and uses thereof
MX2017011269A (es) 2015-03-06 2018-01-12 Pharmakea Inc Inhibidores de lisil oxidasa tipo 2 fluorinados y usos de los mismos.
CN108137807B (zh) * 2015-08-19 2020-09-29 日产化学工业株式会社 液晶取向剂中使用的酰亚胺系聚合物
EP4385571A2 (en) 2016-09-07 2024-06-19 Pharmakea, Inc. Uses of a lysyl oxidase-like 2 inhibitor related applications
KR102587178B1 (ko) 2016-09-07 2023-10-06 파마케아, 인크. 리실 옥시다아제-유사 2 억제제의 결정질 형태 및 제조 방법
WO2019175464A1 (en) 2018-03-14 2019-09-19 Orion Corporation Compounds useful as inhibitors of sodium-calcium exchanger (ncx)
IL300113A (en) 2020-07-28 2023-03-01 Jazz Pharmaceuticals Ireland Ltd Compressed cyclic RAF inhibitors and methods of using them
CN115850258A (zh) * 2022-12-27 2023-03-28 东北林业大学 一种马赛替尼的合成方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2820817A (en) * 1954-02-04 1958-01-21 Mcneilab Inc Oxygenated indan compounds and method of making the same
BE650081A (sr) 1963-07-03
US3862232A (en) * 1963-07-03 1975-01-21 Upjohn Co 1-(p-hydroxyphenyl)-2-phenyl-6-(2-diethylaminoethoxy)-3,4-dihydronaphthalene and the salts thereof
GB1154119A (en) 1968-05-20 1969-06-04 Merck Ag E 3-Alkyl-Flavanones
JPH04113839A (ja) * 1990-09-05 1992-04-15 Mitsubishi Petrochem Co Ltd ポリカーボネート樹脂積層物
FR2733685B1 (fr) * 1995-05-05 1997-05-30 Adir Utilisation des derives du benzopyrane pour l'obtention de compositions pharmaceutiques destinees au traitement des pathologies liees a l'echangeur c1-/hc03-, na+ independant
JPH0967336A (ja) 1995-09-04 1997-03-11 Kanebo Ltd 新規なイソチオウレア誘導体
WO1998043943A1 (fr) 1997-03-27 1998-10-08 Taisho Pharmaceutical Co., Ltd. Derives de 2-phenoxyaniline
JPH1149752A (ja) * 1997-08-05 1999-02-23 Taisho Pharmaceut Co Ltd フェノキシピリジン誘導体
DE19742508A1 (de) * 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
DK1031556T3 (da) 1997-10-20 2003-02-24 Taisho Pharmaceutical Co Ltd 2-phenoxyanilinderivater
JPH11302235A (ja) 1998-04-15 1999-11-02 Taisho Pharmaceut Co Ltd フェノキシアルキルアミン誘導体
AU4360200A (en) 1999-04-23 2000-11-10 Bristol-Myers Squibb Company Bicyclic acyl guanidine sodium/proton exchange inhibitors and method
CZ2002802A3 (cs) * 1999-09-17 2003-02-12 Nissan Chemical Industries, Ltd. Benzopyranové deriváty
FI20011507A0 (fi) 2001-07-10 2001-07-10 Orion Corp Uusia yhdisteitä

Also Published As

Publication number Publication date
US7482340B2 (en) 2009-01-27
NZ541087A (en) 2008-04-30
CN1745078A (zh) 2006-03-08
CA2512184A1 (en) 2004-07-29
BRPI0406669A (pt) 2005-12-20
NO20053730L (no) 2005-10-07
JP2006516271A (ja) 2006-06-29
FI20030030A0 (fi) 2003-01-09
RS20050528A (en) 2007-06-04
IS7969A (is) 2005-08-02
IL169435A0 (en) 2007-07-04
UA81941C2 (uk) 2008-02-25
AU2004203943B2 (en) 2009-09-17
EP1583759A1 (en) 2005-10-12
EA200501104A1 (ru) 2005-12-29
AU2004203943A1 (en) 2004-07-29
PL378326A1 (pl) 2006-03-20
KR20050095601A (ko) 2005-09-29
HRP20050703A2 (en) 2005-10-31
US20060241147A1 (en) 2006-10-26
WO2004063191A1 (en) 2004-07-29
MXPA05007435A (es) 2005-09-12
CN100457752C (zh) 2009-02-04
EA008539B1 (ru) 2007-06-29
AR042733A1 (es) 2005-06-29
NO20053730D0 (no) 2005-08-03

Similar Documents

Publication Publication Date Title
ZA200505461B (en) Pyridine derivatives usefl for inhibiting sodium/calcium exchange system
EP0611003B1 (en) Substituted phenyl sulfonamides as selective B3 agonists for the treatment of diabetes and obesity
EP2054411B1 (en) Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
US6777414B1 (en) Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same
CZ303639B6 (cs) N-Oxid derivátu 4-fenylpyridinu, zpusob jeho prípravy a lécivo s jeho obsahem
EP0359547B1 (en) Pyridine compounds and pharmaceutical use thereof
EP0605031A1 (en) Phenoxy- and phenoxyalkyl-piperidines as antiviral agents
CN111183130A (zh) 苯并杂环衍生物及包含其的医药组合物
WO1992003427A1 (en) Ketone compound and remedy for osteoporosis
CA2452918C (en) New compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias
ES2251827T3 (es) Derivado de piridina y producto farmaceutico que lo contiene.
AU2002321339A1 (en) New compounds, which are potent inhibitors of NA+/CA2+ exchange mechanism and are useful in the treatment of arrhythmias
FR2806722A1 (fr) Derives de n-(heterocyclylbutyl) benzene-ou pyridine sulfonamide, leur preparation et leur application en therapeutique
KR100534621B1 (ko) 혈관형성을 저해하는 5-치환된-1,2,4-티아디아졸릴 유도체
MXPA00009342A (en) Pyridine derivative and pharmaceutical containing the same